Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation
Huanling Guo, Jinsheng Huang, Tan Yang, Wenxin Wu, Tongyi Huang, Nan Zhang, Shuling Chen, Chunyang Zhang, Xiaoyan Xie, Xintao Shuai, Ming Xu
Topics & Concepts
StingCancer researchTumor microenvironmentMedicineImmune systemImmunotherapyImmune checkpointAgonistTumor progressionImmunopotentiatorCytotoxic T cellBlockadeCD8PharmacologyCancerImmunologyInternal medicineChemistryReceptorIn vitroAerospace engineeringEngineeringBiochemistryCancer Immunotherapy and Biomarkersinterferon and immune responsesImmunotherapy and Immune Responses